Alembic receives FDA tentative nod for generic OpsumitThe Food and Drug Administration has given Alembic tentative approval for macitentan tablets in a dosage strength of 10 mg. Lupin gets FDA blessing for generic VigabatrinVigabatrin for Oral Solution had a market value of roughly $275 million, according to December 2021 IQVIA data. AAM launches Markup Madness campaign The Markup Madness campaign is aimed at highlighting the role that the big men in the middle play in running up the score on patients, the organization said. Teva debuts Revlimid generic Teva’s lenalidomide capsules are used in adults for the treatment of multiple myeloma in combination with the medicine dexamethasone. Akorn, Théa Pharma complete branded ophthalmic products sale Moving forward Akorn said it will invest in its facilities and targeted avenues of growth, such as its human generics and animal care businesses. Lannett to sell liquid drug manufacturing plant, other assets for $10.5M The sale of Lannett’s liquid drug manufacturing facility in Carmel, N.Y., to a private company, is anticipated to close within the next several weeks. Glenmark obtains FDA OK for generic MetroGel-Vaginal gel MetroGel-Vaginal gel had a market value of approximately $60.4 million for the 12-month period ending November 2021, according to IQVIA. Xiromed, Genzum unveil generic Naftin The medication, a topical antifungal, is the generic of Naftin. Lupin launches generic Renagel The medication, which is the generic of Genzyme's Renagel, is used to treat hyperphosphatemia in patients with chronic kidney disease. FDA approves biosimilar Neupogen Releuko is the third biosimilar to Neupogen approved by the Food and Drug Administration, the company said. First Previous 83 84 85 86 87 Next Last